Academic Journal

Drug and Alcohol Dependence

13 Papers Indexed in Blossom

Published Papers

Interest in receiving psychedelic-assisted therapy among marginalized women: Implications and findings from a community-based study in Canada

This survey study (n=486) assessed the interest a cohort of marginalized women have in receiving psychedelic-assisted therapy (PAT). Of them, 43% (n=211) were interested in receiving PAT while factors associated with an interest in PAT included daily crystal methamphetamine use, lifetime mental health condition, childhood abuse and lifetime psychedelic use.

Published: June 1, 2022
Journal: Drug and Alcohol Dependence
Authors: Argento, E., Bingham, B., Braschel, M., Deering, K., Goldenberg, S., Lavalley, J., Shannon, K.

Open Accessindividual

The Effects of MDMA-Assisted Therapy on Alcohol and Substance Use in a Phase 3 Trial for Treatment of Severe PTSD

This trial (n=90) assessed patterns of alcohol and substance use in patients receiving MDMA-assisted therapy. MDMA was associated with a significant reduction in Alcohol Use Disorder Identification Test (AUDIT) scores when compared to placebo. Changes in Drug Use Disorder Identification Test (DUDIT) scores did not significantly differ between groups.

Published: February 8, 2022
Journal: Drug and Alcohol Dependence
Authors: Brown, R., Coker, A., Doblin, R., Emerson, A., Klaire, S. S., Mitchell, J., Nicholas, C. R., Wang, J. B., Yazar-Klosinski, B.

Open Accessindividual

In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.

This rat study (n=41) compared the hyperthermic side effects of MDMA ( and a deuterium-substituted analog d2-MDMA in rats and found that d2-MDMA produced increases in body temperature that were shorter-lasting and of lower magnitude compared to equivalent doses of MDMA.

Published: March 1, 2020
Journal: Drug and Alcohol Dependence
Authors: Berquist, M. D., Fantegrossi, W. E., Kristensen, J. L., Leth-Petersen, S.

Paywallindividual

Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience

This double-blind, placebo-controlled study (n=16) examined the effects of high-dose psilocybin on subjective experience and brain connectivity in long-term meditators. Results indicate that psilocybin induced profound personal meaning and altered functional connectivity within the default mode network (DMN) and between the DMN and hippocampus, effects that were observable the day after dosing.

Published: February 1, 2017
Journal: Drug and Alcohol Dependence
Authors: Barrett, F. S., Griffiths, R. R., Johnson, M. W.

Paywallmeta

Ibogaine for treating drug dependence. What is a safe dose?

This review (2016) argues that the current doses of ibogaine administered as a treatment for drug dependence are too high and should be reconsidered to avoid toxicity and fatalities.

Published: September 1, 2016
Journal: Drug and Alcohol Dependence
Authors: Galea, S., Newcombe, D., Schep, L. J., Slaughter, R. J.

Open Accessindividual

Therapeutic infusions of ketamine: do the psychoactive effects matter?

This double-blind, randomised, inpatient study (n=8) evaluates the mystical and dissociative effects of ketamine in the treatment of cocaine dependant individuals. Ketamine led to significantly greater acute mystical-type effects than the active control, and mediated motivation to quit cocaine 24h post-infusion.

Published: January 15, 2014
Journal: Drug and Alcohol Dependence
Authors: Anerella, C., Dakwar, E., Hart, C. L., Levin, F. R., Mathew, S. J., Nunes, E. V.

Quick Facts

Papers Indexed: 13
h-Index: 193
Open Access: No
Publisher: Elsevier
Country: Ireland
Website: Visit

Drug and Alcohol Dependence

Published Papers

Interest in receiving psychedelic-assisted therapy among marginalized women: Implications and findings from a community-based study in Canada

The Effects of MDMA-Assisted Therapy on Alcohol and Substance Use in a Phase 3 Trial for Treatment of Severe PTSD

In vivo effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in rodents: Drug discrimination and thermoregulation.

Psilocybin in long-term meditators: Effects on default mode network functional connectivity and retrospective ratings of qualitative experience

Ibogaine for treating drug dependence. What is a safe dose?

Therapeutic infusions of ketamine: do the psychoactive effects matter?

Quick Facts

Company

Product

Legal